News Sentiment

CRSPN sentiment intelligence

CRISPR Therapeutics AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 55 Balanced news tone 3 relevant articles
Exchange MEX Mexico
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 850.00 Week of 17 Jul 2026
Weighted tone 55/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

66/100 classification confidence.

Company focus 3

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

-18.3% over one week, -4.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

CRISPR Therapeutics shares drop after announcing convertible notes sale

Market Reaction

Price moving ahead of tone

59/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 66/100 classification
One-week reaction -18.3% Price reacting lower
Trend fit Trend inactive -4.8% over four weeks
Fair value -14.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 1
Neutral 2
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 3
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
MSN 1
StockInvest.us 1
Investing.com 1

Event Lens

What the news is about

Classified themes
Market update 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-3 of 3